Loading...
Loading...
India's vaccine imports from JAPAN total $31.5K across 11 shipments from 3 foreign suppliers. LIFE TECHNOLOGIES CORPORATION leads with $19.8K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for vaccine โ a concentrated sourcing relationship with select suppliers from JAPAN.

LIFE TECHNOLOGIES CORPORATION is the leading Vaccine supplier from JAPAN to India, with import value of $19.8K across 7 shipments. The top 5 suppliers โ LIFE TECHNOLOGIES CORPORATION, LIFE TECHNOLOGIES HOLDINGS PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LIMITED โ collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | LIFE TECHNOLOGIES CORPORATION | $19.8K | 7 | 62.9% |
| 2 |
| LIFE TECHNOLOGIES HOLDINGS PTE LTD |
| $9.4K |
| 3 |
| 29.9% |
| 3 | LIFE TECHNOLOGIES HOLDINGS PTE LIMITED | $2.3K | 1 | 7.3% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $26.7K | 9 | 84.7% |
| 2 | INSTITUTE FOR STEMCELL SCIENCE & REGENERATIVE MEDI | $4.8K | 2 | 15.3% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Vaccine suppliers from JAPAN to India include LIFE TECHNOLOGIES CORPORATION, LIFE TECHNOLOGIES HOLDINGS PTE LTD, LIFE TECHNOLOGIES HOLDINGS PTE LIMITED. The leading supplier is LIFE TECHNOLOGIES CORPORATION with import value of $19.8K USD across 7 shipments. India imported Vaccine worth $31.5K USD from JAPAN in total across 11 shipments.
India imported Vaccine worth $31.5K USD from JAPAN across 11 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Vaccine sourced from JAPAN include INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED, INSTITUTE FOR STEMCELL SCIENCE & REGENERATIVE MEDI. The largest buyer is INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED with $26.7K in imports across 9 shipments.
The total value of Vaccine imports from JAPAN to India is $31.5K USD, across 11 shipments and 3 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
11 Verified Shipments
3 suppliers, 2 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists